Similarly, in C57BL/6 mice fed high-fat diets, GSPE reversed weight gain and dyslipidemia in mice, which was thought to be attributed to the ability of GSPE to downregulate the high-fat diet-induced increase of miR-96 and inhibition of mTOR/FOXO1 signaling (89). Here, FOXO1 is linked to metabolic syndrome.